Skip to main content
TruScreen Group Limited logo

TruScreen Group Limited — Investor Relations & Filings

Ticker · TRU ISIN · NZTRUE0001S7 NZX Manufacturing
Open in API
Filings indexed 366 across all filing types
Latest filing 2022-06-01 Director's Dealing
Country NZ New Zealand
Listing NZX TRU

About TruScreen Group Limited

https://www.truscreen.com

TruScreen Group Limited develops and manufactures a proprietary cervical cancer screening system that utilizes opto-electrical technology for the real-time detection of precancerous and cancerous tissue. The system employs a single-use sensor to measure tissue response to specific electrical and optical stimuli, processing the data through an integrated algorithm to provide an immediate objective result. By eliminating the requirement for laboratory processing, tissue sampling, and specialized pathology infrastructure, the technology facilitates point-of-care screening in diverse clinical environments. The device is designed to address the limitations of traditional cytology, offering a non-invasive, portable solution that enhances the efficiency of screening programs and improves patient access to diagnostic results.

Recent filings

Filing Released Lang Actions
Director and Officer Disclosure Notices
Director's Dealing Classification · 100% confidence The document is a disclosure notice regarding directors and senior managers' relevant interests in the company's shares and derivatives. It includes details of share acquisitions and disposals by a director, Anthony Ho, including the number of shares held before and after the transaction, the nature of the interest, and transaction details such as date, consideration, and number of shares. The document references sections of the Financial Markets Conduct Act 2013, indicating a regulatory compliance disclosure. It is not a financial report, earnings release, or management discussion. It is not an announcement of a report publication but a regulatory disclosure of insider share transactions. This fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length (5558 characters) and content confirm it is a full disclosure notice, not a brief announcement or certification only. Therefore, the correct classification is DIRS with high confidence.
2022-06-01 English
Truscreen Preliminary Results For FY2022
Annual Report Classification · 100% confidence The document is titled 'Preliminary Final Report' and contains consolidated financial statements for the year ended 31 March 2022. It includes detailed financial statements such as the statement of profit or loss, statement of financial position, statement of changes in equity, statement of cash flows, and notes to the financial statements. The content is comprehensive and covers the full fiscal year, indicating it is an annual report. The document is 15,000 characters long, which is substantial and contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K).
2022-05-29 English
Provision for Impairment of Non-Current Assets
Regulatory Filings Classification · 95% confidence The document is an announcement dated 27 May 2022 from TruScreen Group Limited regarding a provision booked for impairment of non-current assets. It mentions the upcoming release of preliminary final results for the year ended 31 March 2022, but does not contain the actual financial results or detailed financial statements. The text is relatively short (3524 characters) and focuses on a specific financial update related to asset impairment rather than a full financial report. It is an announcement about a financial matter rather than the financial report itself. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for filings that do not fit other specific categories and are not full reports.
2022-05-29 English
COGA Trial Validates Superiority of Truscreen
Regulatory Filings Classification · 95% confidence The document is an announcement from TruScreen Group Limited regarding the results of a clinical trial validating their cervical cancer screening method. It is presented as a news release with highlights of the trial outcomes, including statistical data on sensitivity and specificity, and comments from the CEO. The document does not contain comprehensive financial statements, detailed management discussion, or regulatory filing formats. It is a corporate announcement focused on clinical trial results and commercial implications rather than a financial or regulatory report. Therefore, it fits best under the category of a Regulatory Filing (RNS), which is the fallback for miscellaneous announcements that do not fit other specific categories.
2022-04-04 English
Issue of Unlisted Options
Capital/Financing Update Classification · 100% confidence The document is titled 'Truscreen Group Limited Capital Change Notice' and details the issuance of unlisted options (TRUOC) including number issued, exercise price, expiry date, and authority for the issue. It is a formal announcement of a capital change event, specifically the issuance of new financial products (options). The document is relatively short (2760 characters) and focuses solely on capital structure changes without financial statements or performance data. Therefore, it fits the category of Capital/Financing Update (CAP).
2022-03-03 English
TruScreen Achieves Significant Milestones with Distributors
Capital/Financing Update Classification · 90% confidence The document is an announcement from TruScreen Group Limited providing a market update on recent company milestones, including national pricing approval in China, a new sales contract in Zimbabwe, issuance of share options to distributors, and a new appointment in marketing. It contains no financial statements or detailed financial analysis. The content focuses on operational progress, sales contracts, share option issuance, and management appointment. The document is relatively short (6,835 characters) and reads as a corporate update or market announcement rather than a formal financial report or regulatory filing. There is no indication of it being an earnings release, annual or interim report, or any other formal report type. The issuance of share options to distributors is a capital-related update but not a formal capital raising or financing announcement. The appointment of a marketing manager is a management update but not a board or senior management change announcement. Given the nature of the content and the absence of financial data or regulatory form references, the best fitting category is Capital/Financing Update (CAP), as it includes the share options issuance to distributors as an incentive to boost sales, which is a capital structure related update.
2022-03-02 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.